EIF3H and hepatocellular carcinoma: We further performed a survival analysis of the EIF3H using the TCGA dataset and found that high expression of EIF3H was associated with poor prognosis in HCC patients, with both decreased inferior overall survival (OS) and relapse-free survival (RFS) (Fig. 1D, E).